BSE filing, NSE: DLF. Summary written from the filing by ALFA Finder's alert engine.
DLF Ltd: key numbers
- Share price
- ₹666.30
- Market cap
- ₹1,64,930 Cr
- Revenue (annual)
- ₹8,194 Cr
- Net profit (annual)
- ₹4,415 Cr
- P/E (TTM)
- 36.1×Sector 34.0×
- Promoter holding
- 74.08%+0.00% QoQ
- FII holding
- 11.43%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from DLF Ltd
All →DLF Earnings Call Transcript: Key Takeaways
DLF delivered a robust quarter with consolidated revenue of ₹2,298 Cr, significantly bolstered by a ₹738 Cr one-time gain. The narrative centers on a successful luxury sell-out and a strategic transition toward long-term rental income.
DLF Investor Presentation: Key Takeaways
DLF delivered strong Q2FY27 performance with sales bookings of INR 3,800 cr and collections of INR 2,780 cr. The group maintains a robust net cash position of INR 15,084 cr.
DLF Results Update
DLF Limited reported consolidated revenue of Rs 2,298 crore and a net profit of Rs 1,301 crore for Q2FY27, supported by strong operating cash flows.
DLF Promoter Reclassification
DLF Limited's board approved the reclassification of Madhukar Housing and Development Company from 'Promoter' to 'Public' category, subject to stock exchange approval.
DLF Q2 FY27 Results: Net Profit ₹1,301 Cr, Up 10.3% YoY
DLF Ltd reported revenue from operations of ₹1,261 Cr (-23.3% YoY) and net profit of ₹1,301 Cr (+10.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,301 Cr · +10.3% YoY
DLF Board Meeting Date
DLF Limited scheduled a board meeting for October 16, 2026, to consider and approve the standalone and consolidated financial results for the half-year ended September 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.